Rabbit relaxin: the influence of pregnancy and ovariectomy during pregnancy on the plasma profile.
A porcine relaxin radioimmunoassay was developed to evaluate the profile of immunoreactive relaxin in rabbit plasma. Relaxin was nondetectable in pseudopregnant (Days 1, 4, 5-8, 12, and 16), nonpregnant, and male rabbits. However, in pregnant rabbits, relaxin was detected during the peri-implantation period (Days 4-9). Peak concentrations were reached on Day 15 and were maintained until parturition (Day 32). Relaxin concentrations abruptly decreased on Day 1 postpartum to low but detectable concentrations that were unchanged during the first week postpartum. In contrast, progesterone concentrations peaked earlier (Day 13), decreased after Day 25, and were not detectable on Day 1 postpartum. The effect of ovariectomy on the profile of plasma relaxin was evaluated. Four pregnant rabbits were ovariectomized (Day 13) and treated with medroxyprogesterone acetate to maintain pregnancy. As in normal pregnant rabbits, relaxin was observed initially during the peri-implantation period (Days 4-9) and increased to peak concentrations by Day 16. These concentrations were maintained until parturition and abruptly decreased on Day 1 postpartum to low yet detectable concentrations during the first week postpartum. The concentrations of relaxin in the plasma of ovariectomized medroxyprogesterone-treated rabbits were not different from those in three sham controls. These results indicate that the ovary is not a significant source of relaxin in pregnant rabbits. The unique observation of the presence of relaxin during the peri-implantation period suggests that this hormone has a role in preparing the rabbit uterus for implantation. The continued presence of relaxin during the first week postpartum may represent residual hormone, or it may suggest a physiological role during the early postpartum period.
Lee
V H
VH
University of South Alabama College of Medicine, Department of Structural and Cellular Biology, Mobile 36688.
Fields
P A
PA
D000818:Animals; D005260:Female; D008297:Male; D008525:Medroxyprogesterone / Q000031:analogs & derivatives / Q000494:pharmacology; D017258:Medroxyprogesterone Acetate; D010052:Ovariectomy; D010920:Placenta / Q000378:metabolism; D049590:Postpartum Period / Q000097:blood; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000097:blood* / Q000502:physiology; D011555:Pseudopregnancy / Q000097:blood; D011817:Rabbits; D011863:Radioimmunoassay; D012065:Relaxin / Q000097:blood* / Q000378:metabolism
D012065:Relaxin; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone